Compass Therapeutics Inc. (CMPX) stock news · $367.4M cap
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
This CMPX news page leads with what Compass Therapeutics Inc. filed — not a scraped headline mill.
No cached 8-K sentence for CMPX yet. We will not pad this page with generic market recap.
Latest reported CMPX revenue for 2025-12-31 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CMPX currently screens at market cap $367.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CMPX stock page; for the tape open the quote page.
CMPX stock news FAQ
What is CMPX's latest net income?
Latest cached Compass Therapeutics Inc. (CMPX) net income was -$66.5M. Statements: https://lician.com/financials/cmpx
What is CMPX's market cap?
Compass Therapeutics Inc. (CMPX) market cap is $367.4M on the latest cached fundamentals snapshot.
What kind of company is CMPX?
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Where is CMPX stock news listed?
Cached stock news for Compass Therapeutics Inc. (CMPX) is listed at https://lician.com/news/cmpx. Filings: https://lician.com/sec/cmpx
Not investment advice.